Hematologist-Oncologist: Charles Hemenway, MD | Loyola Medicine

UPDATE: Power outages caused by storms have been resolved at Palos Health South Campus, Elmhurst and River Forest outpatient clinics. Palos Health South Campus has resumed appointments as scheduled. Immediate Care at River Forest will reopen today, August 12, 2020, beginning at noon. Appointments at the Elmhurst clinic will resume as scheduled on Friday, August 14.

COVID-19 (Coronavirus) Update: Learn More About Loyola Medicine Care During COVID-19.

Charles Hemenway, MD, PhD

Charles Hemenway, MD, PhD


Pediatric Hematology/Oncology
Director, M.D./Ph.D. Program

Languages Spoken


Clinical Expertise

  • Anemia In Children And Adolescents
  • Bleeding Disorders In Children And Adolescents

About Dr. Hemenway

Dogs, Hiking, Fishing, Skiing, Canoeing, Gardening

Medical Education

Medical School
University of Massachusetts Medical School
University of Florida - Internal Medicine & Pediatrics
  • Duke University Medical Center - Pediatrics: Pediatric Hematology-Oncology

Board Certification

Pediatric Hematology Oncology, American Board of Pediatrics Subspecialty, Pediatric Hematology & Oncology


  • Emergence of a Ph-negative Clone in a Child With Ph+ ALL. Mehrhoff CJ, Hemenway CS, Suh E, JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
  • Degree of Recruitment of DOT1L to MLL-AF9 Defines Level of H3K79 Di- and Tri-methylation on Target Genes and Transformation Potential Kuntimaddi, A.; Achille, N. J.; Thorpe, J.; Lokken, A. A.; Singh, R.; Hemenway, C. S.; Adli, M.; Zeleznik-Le, N. J.; Bushweller, J. H., Cell reports
  • An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias Barretto, N. N.; Karahalios, D. S.; You, D.; Hemenway, C. S., Journal of experimental therapeutics & oncology
View All ResearchShow Less
  • Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4 Lokken, A. A.; Achille, N. J.; Chang, M. J.; Lin, J. J.; Kuntimaddi, A.; Leach, B. I.; Malik, B.; Nesbit, J. B.; Zhang, S.; Bushweller, J. H.; Zeleznik-Le, N. J.; Hemenway, C. S., Leukemia research
  • CBX8 a component of the Polycomb PRC1 complex, modulates DOT1L-mediated gene expression through AF9/MLLT3, Malik, B.; Hemenway, C. S., FEBS letters
  • Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes Chang, M. J.; Wu, H.; Achille, N. J.; Reisenauer, M. R.; Chou, C. W.; Zeleznik-Le, N. J.; Hemenway, C. S.; Zhang, W., Cancer research
  • Hsp90 directly modulates the spatial distribution of AF9/MLLT3 and affects target gene expression. Lin, J. J.; Hemenway, C. S., Journal of Biological Chemistry
  • Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents. Bennett, C. A.; Winters, A. C.; Barretto, N. N.; Hemenway, C. S., Leukemia research
  • The AF4-mimetic peptide PFWT, induces necrotic cell death in MV4-11 leukemia cells., Palermo, C. M.; Bennett, C. A.; Winters, A. C.; Hemenway, C. S., Leukemia research
  • Hurricane Katrina's impact on pediatric and adult patients with sickle cell disease. Karras, N. A.; Hemenway, C. S., Journal of Health Care for the Poor & Underserved
  • Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner. Zhang, W.; Xia, X.; Reisenauer, M. R.; Hemenway, C. S.; Kone, B. C., Journal of Biological Chemistry
  • Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases Reiser, J.; Zhang, X. Y.; Hemenway, C. S.; Mondal, D.; Pradhan, L.; La Russa, V. F., Expert Opinion on Biological Therapy
  • MLL fusion partners AF4 and AF9 interact at subnuclear foci Erfurth, F.; Hemenway, C. S.; de Erkenez, A. C.; Domer, P. H., Leukemia
  • The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells Srinivasan, R. S.; Nesbit, J. B.; Marrero, L.; Erfurth, F.; LaRussa, V. F.; Hemenway, C. S., Leukemia
  • The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor Srinivasan, R. S.; de Erkenez, A. C.; Hemenway, C. S., Oncogene
  • The polycomb protein MPc3 interacts with AF9 an MLL fusion partner in t(9;11)(p22;q23) acute leukemias, Hemenway, C. S.; de Erkenez, A. C.; Gould, G. C., Oncogene
  • Identification and analysis of a third mouse Polycomb gene MPc3, Hemenway, C. S.; Halligan, B. W.; Gould, G. C.; Levy, L. S., Gene